CY1114025T1 - COMPOSITION FOR SUSPENSION - Google Patents

COMPOSITION FOR SUSPENSION

Info

Publication number
CY1114025T1
CY1114025T1 CY20131100432T CY131100432T CY1114025T1 CY 1114025 T1 CY1114025 T1 CY 1114025T1 CY 20131100432 T CY20131100432 T CY 20131100432T CY 131100432 T CY131100432 T CY 131100432T CY 1114025 T1 CY1114025 T1 CY 1114025T1
Authority
CY
Cyprus
Prior art keywords
compositions
suspension
composition
proteasome inhibitors
cyclodextrin
Prior art date
Application number
CY20131100432T
Other languages
Greek (el)
Inventor
Evan R Lewis
Mark Nguyen Ho
Fabiana N Fonseca
Original Assignee
Onyx Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP10178998A external-priority patent/EP2260835B1/en
Application filed by Onyx Therapeutics, Inc. filed Critical Onyx Therapeutics, Inc.
Publication of CY1114025T1 publication Critical patent/CY1114025T1/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Οι συνθέσεις που περιλαμβάνουν έναν ή περισσότερους αδιάλυτους πρακτικά αναστολείς πρωτεασώματος και κυκλοδεξτρίνη, ιδιαίτερα μια υποκατεστημένη κυκλοδεξτρίνη, ουσιαστικά αυξάνουν τη διαλυτότητα αυτών των αναστολέων πρωτεασώματος και διευκολύνουν τη χορήγηση τους. Αυτές οι συνθέσεις περιλαμβάνουν προαιρετικά ένα ρυθμιστικό. Οι μέθοδοι θεραπευτικής αντιμετώπισης χρησιμοποιώντας αυτές τις συνθέσεις κοινοποιούνται επίσης.Compositions comprising one or more practically insoluble proteasome inhibitors and cyclodextrin, particularly a substituted cyclodextrin, substantially increase the solubility of these proteasome inhibitors and facilitate their administration. These compositions optionally include a buffer. Methods of treatment using these compositions are also disclosed.

CY20131100432T 2004-12-07 2013-05-30 COMPOSITION FOR SUSPENSION CY1114025T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63436604A 2004-12-07 2004-12-07
US65593005A 2005-02-23 2005-02-23
EP10178998A EP2260835B1 (en) 2004-12-07 2005-12-07 Composition for proteasome inhibition

Publications (1)

Publication Number Publication Date
CY1114025T1 true CY1114025T1 (en) 2016-07-27

Family

ID=58449087

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20131100432T CY1114025T1 (en) 2004-12-07 2013-05-30 COMPOSITION FOR SUSPENSION
CY20151100923T CY1117507T1 (en) 2004-12-07 2015-10-15 COMPOSITION FOR SUSPENSION

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY20151100923T CY1117507T1 (en) 2004-12-07 2015-10-15 COMPOSITION FOR SUSPENSION

Country Status (1)

Country Link
CY (2) CY1114025T1 (en)

Also Published As

Publication number Publication date
CY1117507T1 (en) 2017-04-26

Similar Documents

Publication Publication Date Title
CY1111489T1 (en) COMPOUNDS FOR SUSPENSION
CY1116693T1 (en) A combination of azelastin and cycloneside
NO2023022I1 (en) cobimetinib, optionally in any form protected by the basic patent, including harmaceutically acceptable salts and sovates thereof, particularly cobimetinib hemifumarate
CY1113192T1 (en) UNIONS AND METHODS FOR THE SUSPENSION OF SUSPENSION PROGRESS THROUGH AURORA SUSPENSION
CY1113386T1 (en) PROJECTOR SUSPENSIONS
EA200701065A1 (en) INJECTABLE COMPOSITIONS CONTAINING NANODISPERS Olanzapine
CY1116373T1 (en) PHARMACEUTICAL PARTICLES CONTAINING METHYLNALTREXON
CY1113963T1 (en) PHARMACEUTICAL COMPOSITIONS WHICH INCLUDE ACTIVIA-COMPETITORS AND USE THESE IN PREVENTION OR MULTIPLE
CY1107294T1 (en) LOCAL COMPOSITION CONTAINING A VITAMIN D OR A VERSION OF VITAMIN D AND A VULNERABLE CYTICOSTEROID
NO20081554L (en) Isoindollide compounds and compositions comprising the same, and their use
CY1106679T1 (en) AZADICYCLIC HETEROCYCLIC COMPOUNDS AS CANNABINOID RECEPTOR MODIFIERS
EA200802390A1 (en) CONSENTS OF ANALOGUES OF AZIRIDELEPOTILON AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MXPA05013977A (en) Methods and compositions for treating amyloid-related diseases.
EA200501928A1 (en) Pyrrolodihydroisoquinols as inhibitors of PDE10
CY1109916T1 (en) Benzimidazolo-thiophene compounds as PLK inhibitors
CY1111983T1 (en) PHARMACEUTICAL COMPOSITION AND METHOD OF USE OF ANTIFICIAL AGENT IN COMBINATION
CY1109465T1 (en) NEW PHARMACEUTICAL MEDICINES FORMONTAFINILIS
NO20063293L (en) Pharmaceutical compounds
CY1117507T1 (en) COMPOSITION FOR SUSPENSION
CY1114113T1 (en) COMBINATION OF A VASCULAR IF VASCULAR INHIBITOR AND A BETA-INHIBITOR
CY1114373T1 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING DROCHIDORA
CY1114328T1 (en) AMINOCINOLONES AS GSK-3 INHIBITORS
CY1114511T1 (en) CARBONYLAMINE PYRROLOPYRAZOLES, POSSIBLE CHINASE INHIBITORS